© 2026 Western New York Public Broadcasting Association

140 Lower Terrace St.
Buffalo, NY 14202

Toronto Address:
130 Queens Quay E.
Suite 903
Toronto, ON M5A 0P6


Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
BTPM NPR Newsroom | Phone: 716-845-7040
Differing shades of blue wavering throughout the image
Give Now
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Developing a low-cost, patent-free vaccine for the world

NPR
Published January 10, 2022 at 12:20 PM EST
A researcher works on a vaccine against the new coronavirus COVID-19 at the Copenhagen's University research lab in Copenhagen, Denmark, on March 23, 2020. (Thibault Savary/AFP via Getty Images)
A researcher works on a vaccine against the new coronavirus COVID-19 at the Copenhagen's University research lab in Copenhagen, Denmark, on March 23, 2020. (Thibault Savary/AFP via Getty Images)

Vaccinating the world may seem like a lofty goal, but medical experts say it’s what we need to stop COVID-19 in its tracks.

Enter CORBEVAX. This low-cost, patent-free vaccine was developed by Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, along with his colleague Maria Elena Bottazzi.

Hotez joins host Tonya Mosley to discuss the importance of vaccinating the world.

This article was originally published on WBUR.org.

Copyright 2022 NPR. To see more, visit https://www.npr.org.